Assessment of platelet activation after ischemic stroke could be clinically valuable if platelet markers existed that predict the risk of recurrent events and reflect the effect of antiplatelet therapy...
Keywords: Sekundärprophylaxe, Schlaganfall, Thrombozyten, Thrombozyten-aggregationshemmer, Thrombozytendiagnostik
10/2005 | LaboratoriumsMedizin, Walter de Gruyter